Hepatocellular carcinoma: New and emerging risks

被引:22
|
作者
Sherman, Morris [1 ,2 ]
机构
[1] Univ Toronto, Dept Med, Toronto, ON M5N 2N2, Canada
[2] Univ Hlth Network, Toronto, ON M5N 2N2, Canada
关键词
Cirrhosis; Hepatitis B; Hepatitis C; Hepatocellular carcinoma;
D O I
10.1016/S1590-8658(10)60508-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The underlying liver diseases that put patients at risk for the development of hepatocellular carcinoma (HCC) are well known. However, it is equally well known that not all patients with these conditions will develop HCC. Therefore within the disease groups (hepatitis B, cirrhosis, etc.,) there are other factors that indicate greater or lesser risk. Some markers of risk are common to all causes of HCC, such as cellular dysplasia, advancing age and male gender. Others factors are specific to individual diseases. This has been well established for hepatitis B in which viral load, genotype and antigen status are major contributors to increased risk of HCC. For both hepatitis B and hepatitis C attempts have been made to identify those individuals at greatest risk using data from large cohort studies. In addition to the common causes of liver disease that are recognized to be causes of HCC non-alcoholic fatty liver disease and possibly diabetes are newly emerging risk factors. (C) 2010 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:S215 / S222
页数:8
相关论文
共 50 条
  • [21] The Emerging Role of Circular RNAs in Hepatocellular Carcinoma
    Qiu, Li-Peng
    Wu, Yi-Hang
    Yu, Xiao-Feng
    Tang, Qi
    Chen, Liang
    Chen, Ke-Ping
    JOURNAL OF CANCER, 2018, 9 (09): : 1548 - 1559
  • [22] Ferroptosis and hepatocellular carcinoma: the emerging role of lncRNAs
    Chen, Haoran
    Han, Zhongyu
    Su, Junyan
    Song, Xuanliang
    Ma, Qingquan
    Lin, Yumeng
    Ran, Zijin
    Li, Xueping
    Mou, Rongkun
    Wang, Yi
    Li, Dongxuan
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [23] The androgen receptor as an emerging target in hepatocellular carcinoma
    Kanda, Tatsuo
    Yokosuka, Osamu
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2015, 2 : 91 - 99
  • [24] Emerging roles of FGF signaling in hepatocellular carcinoma
    Zheng, Nana
    Wei, Wenyi
    Wang, Zhiwei
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 (01) : 1 - 6
  • [25] Hepatocellular carcinoma: An emerging problem with hepatitis C
    Jeffers, L
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2000, 92 (08) : 369 - 371
  • [26] The Emerging Roles of Exosomes in the Chemoresistance of Hepatocellular Carcinoma
    Zhang, Jie
    Song, Qianqian
    Wu, Mengna
    Zheng, Wenjie
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (01) : 93 - 109
  • [27] Bone metastases in hepatocellular carcinoma: an emerging issue
    Longo, Vito
    Brunetti, Oronzo
    D'Oronzo, Stella
    Ostuni, Carmela
    Gatti, Pietro
    Silvestris, Franco
    CANCER AND METASTASIS REVIEWS, 2014, 33 (01) : 333 - 342
  • [28] Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets
    Pessino, Greta
    Scotti, Claudia
    Maggi, Maristella
    CANCERS, 2024, 16 (05)
  • [29] Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma
    Pu Chen
    Qiong-Xuan Fang
    Dong-Bo Chen
    Hong-Song Chen
    World Journal of Gastrointestinal Oncology, 2021, 13 (07) : 673 - 683
  • [30] Emerging theragnostic radionuclide applications for hepatocellular carcinoma
    Nyakale, N. E.
    Aldous, C.
    Gutta, A. A.
    Khuzwayo, X.
    Harry, L.
    Sathekge, M. M.
    FRONTIERS IN NUCLEAR MEDICINE, 2023, 3